Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waleed Ghanima

Showing results (141-150 of 205) with videos related to

Pageof 21
Sort By:
Thrombosis and Haemostasis|January 12, 2022
External Validation of the Patient-Reported Villalta Scale for the Diagnosis of Postthrombotic SyndromeSara Ng, Marc A Rodger, Waleed Ghanima, et al.
Eclinicalmedicine|November 12, 2019
Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for RomiplostimChristian Fynbo Christiansen, Shahram Bahmanyar, Waleed Ghanima, et al.
Journal of Comparative Effectiveness Research|September 25, 2025
Comparative safety and effectiveness of direct oral anticoagulants and warfarin in patients with venous thromboembolism in Finland, Norway and SwedenWaleed Ghanima, Hanna Pohjantähti, Dimitra Lambrelli, et al.
Blood Advances|June 6, 2020
Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosisSynne G Fronas, Anders E A Dahm, Hilde S Wik, et al.
Blood Advances|October 15, 2020
Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosisSynne G Fronas, Camilla T Jørgensen, Anders E A Dahm, et al.
British Journal of Haematology|January 13, 2021
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopeniaRalph Boccia, Nichola Cooper, Waleed Ghanima, et al.
European Journal of Haematology|November 26, 2018
Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study GroupGunnar Birgegard, Jan Samuelsson, Erik Ahlstrand, et al.
Trials|January 7, 2021
Pulmonary rehabilitation to improve physical capacity, dyspnea, and quality of life following pulmonary embolism (the PeRehab study): study protocol for a two-center randomized controlled trialStacey Haukeland-Parker, Øyvind Jervan, Hege Hølmo Johannessen, et al.
Platelets|March 20, 2019
Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonistsLamya Garabet, Waleed Ghanima, Anbjørg Rangberg, et al.
American Journal of Hematology|November 28, 2023
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trialNichola Cooper, Waleed Ghanima, Nicola Vianelli, et al.
Pageof 21

Showing results (141-150 of 205) with videos related to

Sort By:
Pageof 21
Thrombosis and Haemostasis|January 12, 2022
External Validation of the Patient-Reported Villalta Scale for the Diagnosis of Postthrombotic SyndromeSara Ng, Marc A Rodger, Waleed Ghanima, et al.
Eclinicalmedicine|November 12, 2019
Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for RomiplostimChristian Fynbo Christiansen, Shahram Bahmanyar, Waleed Ghanima, et al.
Journal of Comparative Effectiveness Research|September 25, 2025
Comparative safety and effectiveness of direct oral anticoagulants and warfarin in patients with venous thromboembolism in Finland, Norway and SwedenWaleed Ghanima, Hanna Pohjantähti, Dimitra Lambrelli, et al.
Blood Advances|June 6, 2020
Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosisSynne G Fronas, Anders E A Dahm, Hilde S Wik, et al.
Blood Advances|October 15, 2020
Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosisSynne G Fronas, Camilla T Jørgensen, Anders E A Dahm, et al.
British Journal of Haematology|January 13, 2021
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopeniaRalph Boccia, Nichola Cooper, Waleed Ghanima, et al.
European Journal of Haematology|November 26, 2018
Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study GroupGunnar Birgegard, Jan Samuelsson, Erik Ahlstrand, et al.
Trials|January 7, 2021
Pulmonary rehabilitation to improve physical capacity, dyspnea, and quality of life following pulmonary embolism (the PeRehab study): study protocol for a two-center randomized controlled trialStacey Haukeland-Parker, Øyvind Jervan, Hege Hølmo Johannessen, et al.
Platelets|March 20, 2019
Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonistsLamya Garabet, Waleed Ghanima, Anbjørg Rangberg, et al.
American Journal of Hematology|November 28, 2023
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trialNichola Cooper, Waleed Ghanima, Nicola Vianelli, et al.
Pageof 21